Carolyn Y. Johnson

Washington, D.C.

Science reporter

Education: Amherst College, BA in Physics and English; MIT, MS in Science Writing

Carolyn Johnson is a science reporter. She previously covered the business of health, the pharmaceutical industry and the affordability of health care to consumers. Before coming to the Post, she covered science at the Boston Globe.
Latest from Carolyn Y. Johnson

Omicron-based coronavirus booster shots will roll out this fall

The FDA announced that the fall shots would include a component from BA.4 and BA.5, the omicron subvariants gaining ground in the United States.

June 30, 2022

Coronavirus vaccines should be updated for fall, FDA advisers say

The panel recommended that coronavirus shots be updated to more closely reflect the circulating virus.

June 28, 2022

FDA advisers recommend authorizing Novavax coronavirus vaccine

The Novavax vaccine is a protein vaccine, a more traditional technology found in other commonly used immunizations such as hepatitis B and influenza.

June 7, 2022

A more traditional coronavirus shot on the way for some unable to wait

The Novavax vaccine has been long awaited by some people allergic to the other shots.

June 5, 2022

White House says coronavirus shots for kids under 5 could begin June 21

The availability of vaccines depends on decisions by regulators and public health officials.

June 2, 2022

Pfizer seeks authorization of coronavirus shot for children under 5

Pfizer is requesting authorization for a three-shot pediatric vaccine for children younger than 5.

June 1, 2022

There’s still no HIV vaccine. The science behind coronavirus shots may help.

The technology used in coronavirus shots is opening a promising avenue of research in the pursuit of an HIV vaccine.

June 1, 2022

Pfizer covid shot 80 percent effective in younger kids, early data shows

The data is a step toward a vaccine for infants, toddlers and children younger than 5 — the last age group to lack access to a coronavirus vaccine in the United States.

May 23, 2022

First shipment of baby formula arrives in Indianapolis from Germany

A U.S. military plane brought more than 70,000 pounds of hypoallergenic baby formula as part of an administration initiative to quickly address a national shortage of the food source.

May 22, 2022

FDA authorizes a coronavirus booster shot for children as young as 5

A third shot of the Pfizer-BioNTech coronavirus vaccine would become available to 5-to-11-year-olds as cases rise nationally.

May 17, 2022